Global Infertility Treatment Devices and Equipment Market, Product Type (Ovum Aspiration Pumps, Sperm Separation Devices, Sperm Analyzer Systems, Micromanipulator Systems, Incubators, Others), Procedure (Assisted Reproductive Technology, Artificial Insemination, Fertility Surgery), End-User (Fertility Clinics, Hospitals and Other Healthcare Facilities, and Clinical Research Institutes) – Industry Trends and Forecast to 2029
Market Analysis and Size
According to the United Nations, the global fertility rate is expected to fall to 2.4 births per woman by 2030 and 2.2 births per woman by 2050. (UN). Currently, 46% of the world's population resides in countries with low fertility rates. Another 46% of the population lives in nations with intermediate fertility, and the last 8% lives in high fertility countries.
Data Bridge Market Research analyses that the infertility treatment devices and equipment market which was USD 1249.80 million in 2021, would rocket up to USD 2508.64 million by 2029, and is expected to undergo a CAGR of 9.10% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
The market for infertility treatment devices and equipment was dominated by sperm separation devices. In most ARTs, such as IVF and artificial insemination, sperm separation devices are used. These instruments are critical for ARTs because they give pure samples for subsequent operations.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Ovum Aspiration Pumps, Sperm Separation Devices, Sperm Analyzer Systems, Micromanipulator Systems, Incubators, Others); Procedure (Assisted Reproductive Technology, Artificial Insemination, Fertility Surgery); End User (Fertility Clinics, Hospitals and Other Healthcare Facilities, and Clinical Research Institutes)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
AB Scientific Ltd. (U.S.), Art Biotech Pvt. Ltd. (India), Cook (U.S.), Dxnow, Inc.(U.S), Eppendorf SE (U.S), Esco Micro Pte. Ltd. (Singapore), Hamilton Thorne, Ltd. (U.S), LabIVF Asia Pte Ltd. (Singapore), Rocket Medical plc (U.K), The Cooper Companies, Inc.(U.S), Vitrolife (Sweden), Irvine Scientific (U.S.), Microptic (U.S), The Cooper Companies Inc. (U.S.)
|
|
Market Opportunities
|
|
Infertility Treatment Devices and Equipment Market Dynamics
Drivers
- Increasing Incidence of Infertility in Both Sexes
Infertility is defined by the World Health Organization as an individual's inability to achieve a healthy clinical pregnancy. Infertility can affect both men and women, however the majority of research on the problem has been conducted on women. The average number of children a woman has is referred to as her fertility rate. The global fertility rate is gradually declining due to a variety of variables, including an increase in late marriages and an increase in age-related infertility.
- Innovation and enhancement of technology
The success rate of treatments is increasing as technology improves. For example, increased demand for cryosystems and other associated devices will emerge from the development of storage equipment for temperature-sensitive sperm samples.
- Improvements in assisted reproductive treatments
Time-lapse imaging is one of the most cutting-edge infertility therapies. Time-lapse imaging can be utilised to examine the embryo development process at regular intervals without disturbing the culture. Embryos would be taken out of the incubator every day to be evaluated in earlier monitoring procedures. Embryos can continue in the incubator without disturbing their growth because to advances in technology and the usage of computers.
Opportunities
Many causes contribute to low conception rates, thus the number of people seeking infertility therapy will increase in the future years. Many companies have created novel devices and procedures for fertility treatment that are simple, effective, and cost-effective. The rising incidence of infertility in both sexes and the rising number of fertility clinics and infertility services with government assistance are key factors driving market expansion.
Restraints/Challenges
- Multiplicity and risk of preterm delivery
Several pregnancies are more likely when more than one foetus is transplanted to the mother's uterus during IVF infertility therapy, and if the babies are multiple, the risk of preterm delivery is higher. According to certain research, embryos that grow through IVF infertility treatment are born prematurely and weigh less than normal.
- Ovarian hyperstimulation syndrome
Infertile women utilise injectable fertility medicines like gonadotropins to help them ovulate during IVF infertility treatment. As a result, they develop ovarian hyperstimulation syndrome, which produces swollen and painful ovaries. Mild abdominal pain, bloating, nausea, diarrhoea, and vomiting are common symptoms of this syndrome, which subside after a week. Rapid weight gain and shortness of breath are ovarian hyperstimulation syndrome symptoms.
- Abortion
The rate of miscarriage in women who get pregnant through IVF is the same as it is in women who get pregnant naturally, although the rate of miscarriage rises with the mother's age.
This infertility treatment devices and equipment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the infertility treatment devices and equipment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Infertility Treatment Devices and Equipment Market
COVID-19 sickness began to spread over the world in the first half of 2020, infecting millions of people globally, prompting major countries around the world to impose foot prohibitions and work stoppage orders. This report also examines the impact of the COVID-19 pandemic on the Infertility Treatment Devices and Equipment market, including supply chain analysis, impact assessments on the market size growth rate in various scenarios, and the measures that infertility treatment devices and equipment companies will take in response to the COVID-19 pandemic.
Global Infertility Treatment Devices and Equipment Market Scope
The infertility treatment devices and equipment market is segmented on the basis of type, procedure and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Ovum Aspiration Pumps
- Sperm Separation Devices
- Sperm Analyzer Systems
- Micromanipulator Systems
- Incubators
- Others
Procedure
- Assisted Reproductive Technology
- In Vitro Fertilization
- Intracytoplasmic Sperm Injection
- Others (GIFT, ZIFT, Surrogacy)
- Artificial Insemination
- Intrauterine Insemination
- Intratubal Insemination
- Intracervical Insemination
- Fertility Surgery
- Tubal Ligation Reversal
- Varicocelectomy
- Laparoscopy
Others (Laparotomy, Myomectomy, Microsurgical Reconstruction, Hysteroscopy)
End-User
- Fertility Clinics
- Hospitals and Other Healthcare Facilities
- Clinical Research Institutes
Infertility Treatment Devices and Equipment Market Regional Analysis/Insights
The infertility treatment devices and equipment market is analysed and market size insights and trends are provided by country, type, procedure and end-user as referenced above.
The countries covered in the infertility treatment devices and equipment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America was the second-largest market in 2018 as the fertility rate in the U.S. was at a record low. There were only 62.5 births per 1,000 women, according to the National Center for Health Statistics.
Due to rise in the infertility rate in this region and increased awareness about available treatment choices, Asia Pacific is predicted to develop at the quickest rate in the next years. The availability of various reimbursement programmes in developed regions is expected to further promote regional expansion. For example, the Singapore government contributes about 75% of the cost of several ART operations.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The infertility treatment devices and equipment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for infertility treatment devices and equipment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the infertility treatment devices and equipment market. The data is available for historic period 2010-2020.
Competitive Landscape and Infertility Treatment Devices and Equipment Market Share Analysis
The infertility treatment devices and equipment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to infertility treatment devices and equipment market.
Some of the major players operating in the infertility treatment devices and equipment market are:
- AB Scientific Ltd. (U.S.)
- Art Biotech Pvt. Ltd. (India)
- Cook (U.S.)
- Dxnow, Inc.(U.S)
- Eppendorf SE (U.S)
- Esco Micro Pte. Ltd. (Singapore)
- Hamilton Thorne, Ltd. (U.S)
- LabIVF Asia Pte Ltd. (Singapore)
- Rocket Medical plc (U.K)
- The Cooper Companies, Inc.(U.S)
- Vitrolife (Sweden)
- Irvine Scientific (U.S.)
- Microptic (U.S)
- The Cooper Companies Inc. (U.S.)
SKU-